Home

Schurke Ödland Runden melissa gkavogiani organisch Hof Was

Kinetics of antibody responses dictate COVID-19 outcome | medRxiv
Kinetics of antibody responses dictate COVID-19 outcome | medRxiv

Hydrogen sulfide dysregulates the immune response by suppressing central  carbon metabolism to promote tuberculosis | PNAS
Hydrogen sulfide dysregulates the immune response by suppressing central carbon metabolism to promote tuberculosis | PNAS

Hydrogen sulfide dysregulates the immune response by suppressing central  carbon metabolism to promote tuberculosis | PNAS
Hydrogen sulfide dysregulates the immune response by suppressing central carbon metabolism to promote tuberculosis | PNAS

Transcriptomic similarities and differences in host response between  SARS-CoV-2 and other viral infections - ScienceDirect
Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections - ScienceDirect

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote  inflammation by alveolar macrophages
High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages

Myeloid phenotypes in severe COVID-19 predict secondary infection and  mortality: a pilot study | Annals of Intensive Care | Full Text
Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study | Annals of Intensive Care | Full Text

Myeloid phenotypes in severe COVID-19 predict secondary infection and  mortality: a pilot study | Annals of Intensive Care | Full Text
Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study | Annals of Intensive Care | Full Text

Issue: Cell
Issue: Cell

Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping  Review | medRxiv
Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping Review | medRxiv

Kinetics of antibody responses dictate COVID-19 outcome | medRxiv
Kinetics of antibody responses dictate COVID-19 outcome | medRxiv

Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping  Review | medRxiv
Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping Review | medRxiv

Issue: Cell
Issue: Cell

Transcriptomic similarities and differences in host response between  SARS-CoV-2 and other viral infections - ScienceDirect
Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections - ScienceDirect

Transcriptomic similarities and differences in host response between  SARS-CoV-2 and other viral infections - ScienceDirect
Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections - ScienceDirect

Issue: Cell
Issue: Cell

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote  inflammation by alveolar macrophages
High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages

Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping  Review | medRxiv
Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping Review | medRxiv

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote  inflammation by alveolar macrophages
High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages

Kinetics of antibody responses dictate COVID-19 outcome | medRxiv
Kinetics of antibody responses dictate COVID-19 outcome | medRxiv

Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping  Review | medRxiv
Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping Review | medRxiv

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote  inflammation by alveolar macrophages
High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages

Transcriptomic similarities and differences in host response between  SARS-CoV-2 and other viral infections - ScienceDirect
Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections - ScienceDirect

Myeloid phenotypes in severe COVID-19 predict secondary infection and  mortality: a pilot study | Annals of Intensive Care | Full Text
Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study | Annals of Intensive Care | Full Text

Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping  Review | medRxiv
Characterising COVID-19 as a Viral Clotting Fever: A Mixed Methods Scoping Review | medRxiv

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote  inflammation by alveolar macrophages
High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages